Zubair Israr M, et al. - The use of truncated molecular forms of the B-type natriuretic peptide (BNP) molecule as risk-stratifying biomarkers of acute myocardial infarction (MI) were determined. It was noted that BNP molecular forms are related to poor prognosis at 6 months, 1 year, and at 2 years in patients with acute MIs. Furthermore, BNP 5–32 was useful as a secondary marker in combination with NT-proBNP after GRACE scoring. Overall, a potential role for BNP molecular forms in prognosis and risk stratification after acute MI was shown.